Published in J Antimicrob Chemother on January 09, 2007
Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J Virol (2010) 1.69
Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. Proc Natl Acad Sci U S A (2012) 1.65
Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer. J Virol (2009) 1.21
Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo. J Virol (2013) 0.89
A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells. J Virol (2013) 0.82
Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo. PLoS One (2014) 0.80
Adjuvant high-dose interferon-{alpha} for resected melanoma in a patient with HIV infection. Oncologist (2010) 0.75
HIV infection acquired by a nurse. Eur J Epidemiol (1988) 2.59
Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet (1995) 2.47
Transmission of HIV-associated tuberculosis to health-care workers. Lancet (1992) 2.23
Neurocysticercosis: an unusual presentation of a rare disease. J Neurol (2001) 2.04
Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp65 gene. J Clin Microbiol (2001) 1.95
Human immunodeficiency virus seroprevalence and condom use among female sex workers in Italy. Sex Transm Dis (1998) 1.87
Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer (1997) 1.73
Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients. Tuber Lung Dis (1996) 1.66
How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS) J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.57
Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet (1991) 1.56
No HIV-1 transmission through lesbian sex. Lancet (1994) 1.56
Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infection. Lancet (1993) 1.55
Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med (1994) 1.48
Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients. J Hepatol (2001) 1.43
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis (2006) 1.34
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts. Infection (2009) 1.33
Candida albicans biotypes in human immunodeficiency virus type 1-infected patients with oral candidiasis before and after antifungal therapy. J Clin Microbiol (1991) 1.29
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS (1994) 1.29
Comparative evaluation of ligation-mediated PCR and spoligotyping as screening methods for genotyping of Mycobacterium tuberculosis strains. J Clin Microbiol (1999) 1.23
A short course of pegylated interferon-alpha in acute HCV hepatitis. J Viral Hepat (2007) 1.18
Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer (2000) 1.13
Syphilis in prostitutes from Eastern Europe. Lancet (1998) 1.13
Rising temperature and the malaria epidemic in Burundi. Trends Parasitol (2001) 1.11
Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest (1995) 1.09
Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting. Antimicrob Agents Chemother (2005) 1.09
Asymptomatic women at high risk of vertical HIV-1 transmission to their fetuses. Br J Obstet Gynaecol (1993) 1.07
Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol (1996) 1.07
Unusual malignant tumours in 49 patients with HIV infection. AIDS (1989) 1.04
Infective endocarditis in patients with human immunodeficiency virus infection. J Infect (2001) 1.03
Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection. AIDS (1999) 1.02
Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis (1995) 1.01
Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: estimates of the population effect of treatment. Italian HIV Seroconversion Study (ISS). J Acquir Immune Defic Syndr (1999) 1.01
Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. J Infect Dis (1999) 1.01
Aetiology of pneumonia following isolated closed head injury. Respir Med (1997) 1.00
Seroprevalence, risk factors and attitude to HIV-1 in a representative sample of lesbians in Turin. Genitourin Med (1994) 1.00
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis. J Antimicrob Chemother (1998) 1.00
Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet (1996) 1.00
A case of dengue type 3 virus infection imported from Africa to Italy, October 2009. Euro Surveill (2010) 0.98
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect (2014) 0.98
The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1997) 0.98
The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis. Infection (2011) 0.98
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone. Hepatology (2001) 0.97
Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis. Transpl Infect Dis (2011) 0.96
Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med (1990) 0.95
Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect (2002) 0.95
Pneumocystis carinii pneumonia during primary HIV-1 infection. Lancet (1993) 0.95
Osteomyelitis caused by Enterobacter cancerogenus infection following a traumatic injury: case report and review of the literature. J Clin Microbiol (2005) 0.93
Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal function. Antimicrob Agents Chemother (2013) 0.93
The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters. AIDS (1989) 0.93
Maraviroc can improve lipid profiles in dyslipidemic patients with HIV: results from the MERIT trial. HIV Clin Trials (2011) 0.93
Phospholipase activity in Cryptococcus neoformans. Mycopathologia (1997) 0.92
Expression of a leptin receptor in immortalized gonadotropin-releasing hormone-secreting neurons. Endocrinology (1999) 0.92
Transmission of HIV-associated tuberculosis to health-care workers. Lancet (1992) 0.92
High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats. Diabetologia (2010) 0.91
Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study. Am J Epidemiol (1996) 0.90
High serum level of soluble CD30 in acute primary HIV-1 infection. Clin Exp Immunol (1997) 0.89
Usefulness of computerized electroencephalography in diagnosing, staging and monitoring AIDS-dementia complex. AIDS (1989) 0.89
Riboflavine and severe lactic acidosis. Lancet (1999) 0.89
Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients. Infection (2007) 0.88
Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy. J Antimicrob Chemother (2013) 0.88
Penetration of didanosine in semen of HIV-1-infected men. J Antimicrob Chemother (2006) 0.88
Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin Exp Immunol (1997) 0.88
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon. J Antimicrob Chemother (2008) 0.88
Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet (1989) 0.88
The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. Infection (2011) 0.87
Invasive candidiasis and candidemia: new guidelines. Minerva Anestesiol (2008) 0.87
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. AIDS (1995) 0.86
Parasitologic findings in percutaneous drainage of human hydatid liver cysts. J Infect Dis (1990) 0.86
Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid. J Antimicrob Chemother (2000) 0.86
Differences in umbilical cord blood units collected during cesarean section, before or after the delivery of the placenta. Gynecol Obstet Invest (2002) 0.86
Sexually transmitted infections in Italy: an overview. Int J STD AIDS (2001) 0.86
Wavefront sensorless modal deformable mirror correction in adaptive optics: optical coherence tomography. Opt Lett (2013) 0.86
Meningoencephalitis caused by Toxoplasma gondii diagnosed by isolation from cerebrospinal fluid in an HIV-positive patient. Scand J Infect Dis (1993) 0.85
Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS. J Acquir Immune Defic Syndr (1992) 0.85
Polyamines in lymphocytes from patients infected by human immunodeficiency virus. Biol Chem Hoppe Seyler (1989) 0.85
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes. J Viral Hepat (2013) 0.85
Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease. Arch Surg (1992) 0.84
Pharmacokinetic interaction between Amprenavir/Ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation. Transplant Proc (2006) 0.84
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients. Infection (2009) 0.84